[go: up one dir, main page]

ES2065673T3 - Procedimiento para aumentar la fertilidad en las hembras. - Google Patents

Procedimiento para aumentar la fertilidad en las hembras.

Info

Publication number
ES2065673T3
ES2065673T3 ES91902626T ES91902626T ES2065673T3 ES 2065673 T3 ES2065673 T3 ES 2065673T3 ES 91902626 T ES91902626 T ES 91902626T ES 91902626 T ES91902626 T ES 91902626T ES 2065673 T3 ES2065673 T3 ES 2065673T3
Authority
ES
Spain
Prior art keywords
females
procedure
increase fertility
mammal
fertility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91902626T
Other languages
English (en)
Inventor
Teresa K Woodruff
Jennie P Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2065673T3 publication Critical patent/ES2065673T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Photolithography (AREA)
  • Containers, Films, And Cooling For Superconductive Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA UN METODO PARA INCREMENTAR LA FERTILIDAD EN UN MAMIFERO HEMBRA QUE COMPRENDE LA ADMINISTRACION AL OVARIO DEL MAMIFERO DE UNA CANTIDAD EFECTIVO DE INHIBINA. ESTE METODO ES ESPECIALMENTE UTIL PARA LA TRANSFERENCIA DE EMBRIONES EN UN SISTEMA DE FERTILIZACION IN VIVO.
ES91902626T 1990-01-08 1991-01-04 Procedimiento para aumentar la fertilidad en las hembras. Expired - Lifetime ES2065673T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46171390A 1990-01-08 1990-01-08

Publications (1)

Publication Number Publication Date
ES2065673T3 true ES2065673T3 (es) 1995-02-16

Family

ID=23833651

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91902626T Expired - Lifetime ES2065673T3 (es) 1990-01-08 1991-01-04 Procedimiento para aumentar la fertilidad en las hembras.

Country Status (9)

Country Link
EP (1) EP0509040B1 (es)
JP (1) JPH05503699A (es)
AT (1) ATE113842T1 (es)
AU (1) AU638310B2 (es)
CA (1) CA2069755A1 (es)
DE (1) DE69105114T2 (es)
DK (1) DK0509040T3 (es)
ES (1) ES2065673T3 (es)
WO (1) WO1991010445A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
AU722150B2 (en) * 1997-03-06 2000-07-20 University Of Adelaide, The Treatment and diagnosis of infertility using TGFbeta or activin
AUPO550897A0 (en) * 1997-03-06 1997-03-27 Luminis Pty Limited Treatment and diagnosis of an infertility condition
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
YU81600A (sh) 1998-06-22 2004-03-12 Medi-Cult A/S. Ispitivanje za ukazivanje na prisustvo jajnih ćelija koje se ne mogu oploditi
EP1163365A4 (en) * 1999-02-25 2002-11-20 Auckland Uniservices Ltd DIAGNOSIS AND THERAPY OF EARLY OVARY FAILURE
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
CA1305829C (en) * 1986-06-24 1992-07-28 Joachim Spiess Ovine inhibin

Also Published As

Publication number Publication date
WO1991010445A1 (en) 1991-07-25
JPH05503699A (ja) 1993-06-17
DE69105114T2 (de) 1995-05-04
AU638310B2 (en) 1993-06-24
CA2069755A1 (en) 1991-07-09
AU7173491A (en) 1991-08-05
DE69105114D1 (de) 1994-12-15
EP0509040B1 (en) 1994-11-09
DK0509040T3 (da) 1995-04-18
ATE113842T1 (de) 1994-11-15
EP0509040A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
ES2139798T3 (es) Matriz de liberacion controlada para productos farmaceuticos.
DE69027992D1 (de) Steigerung der fruchtbarkeit
BR8703957A (pt) Dispositivo feminino para incontinencia urinaria
PT97441A (pt) Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral
ATE64099T1 (de) In-vitro-fruchtbarkeit.
DK0506853T3 (da) Anvendelse af GABA-B selektive agonister som antitussive midler
ES2065673T3 (es) Procedimiento para aumentar la fertilidad en las hembras.
IT1257474B (it) Impiego di inibitori di aromatosi per contraccezione in primati femmine senza influire sul ciclo mestruale
SE8700203L (sv) Pyroglutamidderivat
ATE106464T1 (de) Hebelitze.
EP0661052A4 (en) PHARMACEUTICAL PREPARATION CONTAINING A PROSTAGLANDIN COMPOUND TO BE ADMINISTERED RECTALLY OR VAGINALLY.
DE69100376D1 (de) Verfahren zur hemmung der follikelreifung.
ES2029831T3 (es) Un procedimiento para la preparacion de una composicion contraceptiva para aplicacion a la vagina de un mamifero hembra.
ES515737A0 (es) Metodo para evaluar la fertilidad de hembras.
ES2062520T3 (es) Somatotropina para aumentar la fertilidad en animales.
MX172107B (es) Procedimiento para la desinfeccion de masas para vaciado medicinales
SE7902866L (sv) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
PT89303A (pt) Processo para a preparacao de tienotriciclos e de composicoes farmaceuticas que os contem
ES491002A0 (es) Metodo mejorado para la propagacion in vitro de parasitos debabesia
ES2154805T3 (es) Procedimiento para la obtencion de aminas opticamente activas.
ES483763A1 (es) Un metodo para tratar semen
ES525335A0 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos.
CO4700429A1 (es) Un procedimiento para la preparacion de monohidrato de lora- carbef
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509040

Country of ref document: ES